3 Tesla MRI in Patients With Bladder Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 8, 2009

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Bladder Cancer
Interventions
PROCEDURE

Specimen Ultra-High field MRI

Immediately following removal of the bladder and lymph nodes, the specimens will be transported to the ultra-high-field MRI scanner for high resolution imaging.

DRUG

chemotherapy

The majority of patients will be candidates to receive neoadjuvant chemotherapy prior to radical cystectomy as part of standard clinical care. Patients will most often receive cisplatin based therapy for a period of three months (four 21 day cycles).

PROCEDURE

Cystectomy and Lymphadenectomy

The patient will undergo radical cystectomy and pelvic lymph node dissection with no deviation from standard surgical care. A urinary tract reconstruction will follow as either a continent or incontinent form of diversion.

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT00938145 - 3 Tesla MRI in Patients With Bladder Cancer | Biotech Hunter | Biotech Hunter